featured
Comparison of the Effectiveness of Adalimumab, Etanercept, and Ustekinumab in Psoriasis Patients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The British Journal of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparison of the One and 5-Years Effectiveness of Adalimumab, Etanercept and Ustekinumab in Psoriasis Patients in Daily Clinical Practice: Results From the Prospective BioCAPTURE Registry
Br J Dermatol 2016 Aug 31;[EPub Ahead of Print], J Zweegers, JM Groenewoud, JM van den Reek, ME Otero, PC van de Kerkhof, RJ Driessen, PP van Lümig, MD Njoo, PM Ossenkoppele, JM Mommers, MI Koetsier, WP Arnold, MP Andriessen, AL Kuijpers, MA Berends, W Kievit, EM de JongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.